Cell Cycle-dependent Expression and Centrosome
Localization of a Third Human Aurora/Ipl1-related Protein Kinase,
AIK3*
Masashi
Kimura,
Yoichi
Matsuda
,
Takashi
Yoshioka, and
Yukio
Okano§
From the Department of Molecular Pathobiochemistry, Gifu University
School of Medicine, Tsukasamachi-40, Gifu 500-8705 and the
Laboratory of Animal Genetics, School of Agricultural
Sciences, Nagoya University, Furo-cho,
Chikusa-ku, Nagoya 464-0814, Japan
 |
ABSTRACT |
We earlier isolated cDNAs encoding novel
human protein kinases AIK and AIK2 sharing high amino acid sequence
identities with Drosophila Aurora and Saccharomyces
cerevisiae Ipl1 kinases whose mutations cause abnormal chromosome
segregation. In the present study, a third human cDNA
(AIK3) highly homologous to aurora/IPL1 was
isolated, and the nucleotide sequence was determined. This cDNA
encodes 309 amino acids with a predicted molecular mass of 35.9 kDa.
C-terminal kinase domain of AIK3 protein shares high amino acid
sequence identities with those of Aurora/Ipl1 family protein kinases
including human AIK, human AIK2, Xenopus pEg2, Drosophila Aurora, and yeast Ipl1, whereas the N-terminal
domain of AIK3 protein shares little homology with any other
Aurora/Ipl1 family members. AIK3 gene was assigned to human
chromosome 19q13.43, which is a frequently deleted or rearranged region
in several tumor tissues, by fluorescence in situ
hybridization, somatic cell hybrid panel, and radiation hybrid cell
panel. Northern blot analyses revealed that AIK3 expression
was limited to testis. The expression levels of AIK3 in several cancer
cell lines were elevated severalfold compared with normal fibroblasts.
In HeLa cells, the endogenous AIK3 protein level is low in
G1/S, accumulates during G2/M, and reduces
after mitosis. Immunofluorescence studies using a specific antibody
have shown that AIK3 is localized to centrosome during mitosis from
anaphase to cytokinesis. These results suggest that AIK3 may play a
role(s) in centrosome function at later stages of mitosis.
 |
INTRODUCTION |
Equal segregation of replicated chromosomes to daughter cells is
an important event in the progression of cell cycle. The centrosomes
are thought to play an important role(s) in bipolar spindle formation
and maintenance at M phase. However, the molecular mechanisms of
centrosome and mitotic spindle organization have not been studied well.
In most cancer cells, an abnormality in chromosome number (aneuploidy)
is observed (1-4). The molecular mechanisms of this chromosome number
alteration have not been elucidated, but some molecules that regulate
chromosome segregation were identified, and overexpression or point
mutations of the genes were observed in some cancer cells (5-9). The
proteins that organize centrosome and/or mitotic spindle should be
identified to understand the cell cycle regulation and/or tumorigenesis.
Yeast IPL1 (10) and fly aurora (11) gene products
are known to regulate chromosome segregation and constitute a family of
serine/threonine kinases. Embryos derived from aurora mutant mothers inappropriately display closely paired centrosomes and monopolar spindles (11). Conditional ipl1ts
mutants severely missegregate chromosomes and gain extra chromosomes at
restrictive temperature (12). None of the substrates or the regulators
of these kinases has been identified, but type 1 protein phosphatase
was shown to act in opposition to Ipl1 protein kinase in yeast (10).
Recent investigations revealed the presence of members of Aurora/Ipl1
family kinases in vertebrates, such as human AIK/BTAK (13, 14), human
AIK2 (15, 16), mouse STK-1 (17), mouse AYK1/IAK1 (18, 19), rat AIM-1
(20), or Xenopus pEg2 (21), but the functions of these
proteins have not been studied well.
Among the Aurora/Ipl1 kinase family, human AIK/BTAK, mouse IAK1/AYK1,
and Xenopus pEg2 appear to constitute a subfamily, because these three protein kinases have closely related N-terminal domain as
well as C-terminal kinase domain with each other. In HeLa cells, the
endogenous levels of AIK mRNA and its protein contents
are tightly regulated during cell cycle progression; they are low in
G1/S, accumulate during G2/M, and reduce
rapidly after mitosis. Its protein kinase activity is also enhanced at
mitosis. Immunofluorescence studies using a specific antibody have
shown that AIK/IAK1 protein is localized to the spindle pole during
mitosis, especially from prophase through anaphase (13, 20).
AIK gene was mapped to human chromosome 20q13.2-13.3 (14,
22), and IAK1 gene was mapped to the distal region of mouse
chromosome 2 (23). These two chromosomal regions share homology,
supporting the notion that IAK1 is a mouse homolog of human AIK. This
chromosomal region is amplified in several cancer tissues including
breast and colorectal cancer (24-28), and AIK gene mapped
to human chromosome 20q13.2-13.3 was also amplified and overexpressed
in cancer cell lines and tissues (8, 14). In a recent study,
overexpression of wild type human AIK was shown capable of transforming
rat fibroblasts, indicating that AIK is oncogenic (8). In addition, the
overexpressed AIK protein induced centrosome amplification and
aneuploidy (9).
Human AIK2, rat AIM-1, and mouse STK-1 have high amino acid sequence
identities with each other along their full length, and these three
proteins constitute the second subfamily of the Aurora/Ipl1 protein
kinase family. The protein level of AIK2 elevated at G2/M phase (15). AIM-1 protein localizes at the equator of central spindles
during late anaphase and at the midbody during telophase and
cytokinesis (20). Overexpression of a kinase-inactive AIM-1 disrupts
cleavage furrow formation without affecting nuclear division. In these
cells, cytokinesis frequently fails, resulting in multinucleation and
subsequent cell death. Thus, AIM-1 was shown to be required for proper
progression of cytokinesis in mammalian cells (20). Recently,
STK-1 was mapped to mouse chromosome 11 and linked to TRP53 and GLUT4 (16, 23). AIK2 gene
was mapped to human chromosome 17p13.1 which is a homologous region to
the STK-1 locus of the mouse chromosome (15). This
chromosomal region is the most frequently deleted region in several
cancer tissues (29-31), but mutation or down-regulation of
AIK2 has not yet been identified.
We have cloned a cDNA encoding a third human Aurora/Ipl1-related
kinase, AIK3, which has a high homology with catalytic domain of
Aurora/Ipl1-related kinase members. AIK3 gene is mapped at human chromosome 19q13.43, a region that was reported to be rearranged and deleted in several cancer cells. AIK3 is expressed highly in testis
and several cancer cell lines. AIK3 protein level of M phase was higher
than that of S phase cells. AIK3 is localized at centrosome from
anaphase to cytokinesis in HeLa cells.
 |
EXPERIMENTAL PROCEDURES |
Cloning and Sequencing of a Third Human Aurora/Ipl1-related
Kinase (AIK3) cDNA--
To identify human cDNA sequences
related to AIK or AIK2 cDNA, the
GenBankTM data base was searched, and a cDNA encoding a
novel kinase (AIK3) was identified (AA421265). This cDNA
clone contains only the C-terminal region of kinase domain, and the
full length of cDNA clones was obtained from testis cDNA
library using PCR.1 Primers
used were derived from nucleotide sequences of
gt11 (5'-TATGGGGATTGGTGGCGACGAC-3' or 5'-ACTGGTAATGGTAGCGACCGGC-3') and the
3'-untranslated region of AIK3 cDNA
(5'-GGGAACAGAGGCAGAGGCAGACA-3'). PCR was carried out using the LA PCR
kit (TaKaRa, Kyoto, Japan) for 35 cycles at 94 (1 min), 60 (2 min), and
72 °C (2 min). The amplified products (1 kb) were subcloned into
pCR2.1 vector (Invitrogen), and the nucleotide sequences of several
clones were determined by the dideoxy chain termination method.
Cell Culture and Synchronization--
HeLa (cervical cancer),
HBL100 (breast cancer), and WI38 (normal fibroblast) cells were
cultured in Dulbecco's modified Eagle's medium supplemented with 10%
fetal calf serum (FCS). HepG2 (hepatocellular carcinoma), Raji (B-cell
leukemia), and HL60 (leukemia) were cultured in RPMI 1640 medium
supplemented with 10% FCS. A neuroblastoma cell line NB69 and
hepatocellular carcinoma cell line HuH7 were cultured with RPMI 1640 medium supplemented with 15% FCS and with 1% FCS plus 2%
lactoalbumin, respectively. SK-N-SH (neuroblastoma) and NB1RGB (normal
fibroblast) cells were cultured in
-minimum Eagle's medium
supplemented with 10% FCS. MDA-MB-453 (breast cancer) was cultured in
L15 medium supplemented with 10% FCS.
For S phase synchronization, HeLa cells were synchronized by double
thymidine treatment (32). Cells were treated with 2.5 mM
thymidine for 20-24 h followed by a 10-h release in fresh medium and
subsequent re-treatment with the drug for 16 h. For M phase synchronization, cells were synchronized by double thymidine treatment as above followed by 400 ng/ml nocodazole treatment for 12 h. Cells to be released from the drug treatment were washed with PBS twice
and refed with fresh medium. At appropriate time points, the cells were
harvested for Western blotting.
Chromosome Preparation and Fluorescence in Situ Hybridization
(FISH)--
The direct R-banding FISH method was used for chromosomal
assignment of the human AIK3. Preparation of
R-banded chromosomes and FISH was performed as described (33-35).
Mitogen-stimulated lymphocyte culture was synchronized by thymidine
block, and 5-bromodeoxyuridine was incorporated during the late
replication stage for differential replication staining after the
release from excessive thymidine. R-band staining was performed by
exposure of chromosome slides to UV light after staining with Hoechst
33258. The chromosome slides were hardened at 65 °C for 3 h,
denatured at 70 °C in 70% formamide in 2 × SSC, and then
dehydrated in a 70-85-100% ethanol series at 4 °C.
The 1.0-kb cDNA fragment of AIK3 inserted into
pBluescript was labeled by nick translation with biotin 16-dUTP
(Boehringer Mannheim) following the manufacturer's protocol. The
labeled DNA fragment was ethanol-precipitated with salmon sperm DNA and
Escherichia coli tRNA, and then denatured at 75 °C for 10 min in 100% formamide. The denatured probe was mixed with an equal
volume of hybridization solution to make a final concentration of 50%
formamide, 2 × SSC, 10% dextran sulfate, and 2 mg/ml bovine
serum albumin (Sigma). A 20 µl mixture containing 250 ng of labeled
DNA was put on the denatured slide, covered with parafilm, and
incubated overnight at 37 °C. The slides were washed for 20 min in
50% formamide in 2× SSC at 37 °C, and in 2× and 1× SSC for 20 min each at room temperature. After rinsing in 4× SSC, the slides were
incubated under a coverslip with anti-biotin antibody (Vector
Laboratories) at a 1:500 dilution in 1% bovine serum albumin, 4× SSC
for 1 h at 37 °C. They were washed with 4× SSC, 0.1% Nonidet
P-40 in 4× SSC, 4× SSC for 5 min each, and then stained with
fluorescein anti-goat IgG (Nordic Immunology) at a 1:500 dilution for
1 h at 37 °C. After washing with 4× SSC, 0.1% Nonidet P-40 in
4× SSC, 4× SSC for 10 min on the shaker, the slides were rinsed with
2× SSC and stained with 0.75 µg/ml propidium iodide. Excitation at 450-490-nm wavelength (Nikon filter set B-2A) and near 365 nm (UV-2A)
was used for observation. Kodak Ektachrome ASA100 film was used for microphotography.
Somatic Cell Hybrid and Radiation Hybrid Cell Panel--
PCR was
performed to assign AIK3 gene to human chromosome, using a
DNA panel of human/rodent somatic cell hybrids (NIGMS Human/Rodent) purchased from Coriell Cell Repositories (Camden, NJ). A pair of
oligonucleotide primers was constructed from the coding region (5'-AGAGAAGGAAGGACTGGAGCACC-3' and 5'-ATCTGCAATCTTCACCTCACCCC-3', corresponding to nucleotides 237-259 and 530-552, respectively). PCR
was carried out using the LA PCR kit (TaKaRa, Kyoto, Japan) for 38 cycles at 94 (30 s), 65 (1 min), and 72 °C (1.5 min), and amplified
products were electrophoresed on 2% agarose gel in TAE buffer.
The G3 radiation hybrid cell panel was purchased from Research Genetics
and used as a DNA template for PCR. The same primers and conditions
were used for PCR as in the experiments with the somatic cell hybrid panel.
Northern Hybridization--
Blotted filters with 2 µg of
poly(A)+ RNA per lane from various human tissues were
purchased from CLONTECH. The blot was probed with
32P-labeled random-primed full-length AIK3
cDNA. Hybridization was performed as described (36). The blots were
washed at 55 °C for 1 h in a buffer containing 2× SSC and
0.5% SDS, and signals were visualized by autoradiography using Kodak
BioMax film.
Western Blotting--
Polyclonal antisera against AIK3 were
generated against synthesized peptide (RYQPLERLPLAQILK) corresponding
to the C-terminal region of AIK3 which has little homology with AIK and
AIK2 amino acid sequences. The obtained immune sera were affinity
purified with the peptide and used for Western blotting. For the
control experiment, anti-AIK3 antibody was preincubated with
glutathione S-transferase-AIK3 protein produced in E. coli and then used for Western blotting. Antibody against AIK was
generated and purified as described (13). Antibodies against cyclin B
and ERK2 were purchased from Santa Cruz Biotechnology.
The synchronized cells were washed with ice-cold PBS and harvested by
scraping and then lysed in lysis buffer (50 mM Tris, pH
7.5, 100 mM NaCl, 10 mM sodium diphosphate, 10 mM NaF, 5 mM EGTA, 1 mM EDTA, 1%
(w/v) Nonidet P-40). Cell lysates were subjected to SDS-polyacrylamide
gel electrophoresis (37) and transferred to Immobilon (Millipore) by
standard methods. Membranes were blocked for 2 h in TBST (0.1%
Tween 20, 137 mM NaCl, 20 mM Tris, pH 7.6) with
3% non-fat dry milk (blocking buffer). Probing with the specific antibodies was carried out for 1 h at room temperature in the blocking buffer containing 0.02% sodium azide. After washing 4 times
in TBST, the membranes were probed with 200 ng/ml peroxidase-labeled secondary antibodies for 1 h in TBST. After extensive washing in
TBST, the membranes were processed for enhanced chemiluminescence using
ECL reagents according to the manufacturer's instructions (Amersham
Pharmacia Biotech). ECL exposures were carried out using Kodak BioMax film.
Immunofluorescence Microscopy--
For indirect
immunofluorescence experiments, HeLa cells cultured on cover glasses
were fixed by placing them directly into absolute methanol for 30 s. Extraction was done by incubating the cells with PBS for 10 min at
room temperature. Cells were incubated with the anti-AIK3 antibody for
1 h at 37 °C, washed extensively in PBS, followed by incubation
with the secondary antibody conjugated with Oregon Green (Molecular
Probe) for 1 h at 37 °C. DNA was visualized by adding
4,6-diamidino-2-phenylindole at a concentration of 0.1 µg/ml.
 |
RESULTS |
Cloning of a cDNA Encoding a Third Human Aurora/Ipl1-related
Kinase, AIK3--
Homology search of AIK2 cDNA with
GenBankTM data base revealed the presence of a third
Aurora/Ipl1-related kinase, AIK3. Since this clone did not contain
initiation methionine, a full-length cDNA was obtained by PCR
method with human testis cDNA library. The nucleotide sequences of
several clones were determined and were identical with each other, and
the nucleotide sequence was deposited in DDBJ/EMBL/
GenBankTM (accession number AB017332). This cDNA
encodes 309 amino acids with a predicted molecular mass of 35.9 kDa.
The deduced amino acid sequence contains 11 conserved regions
characteristic of protein kinase catalytic domain at C terminus of the
protein (Fig. 1). Eleven conserved
subdomains known in various protein kinases are indicated by
roman numerals (Fig. 2). AIK3
has KPEN in subdomain VIB and does not have
PXXWXAPE but only PE in subdomain VIII which are
the consensus sequences of serine/threonine kinases, suggesting that
AIK3 must be a serine/threonine kinase but not a tyrosine kinase.

View larger version (55K):
[in this window]
[in a new window]
|
Fig. 1.
Nucleotide and deduced amino acid sequences
of human AIK3 cDNA. The upstream in-frame
stop codons are underlined. The conceptual translation
yields a 309-amino acid protein. Nucleotide and amino acid residue
numbers are shown at the right of each line. These sequence
data are available from DDBJ/EMBL/GenBankTM Data Libraries
under GenBankTM accession number AB017332.
|
|

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 2.
Amino acid alignment of sequences of human
AIK3, human AIK, human AIK2, Drosophila Aurora, and
S. cerevisiae Ipl1. Amino acids identical with
AIK3 are indicated by asterisks, and gaps are
introduced into sequences to optimize alignments. Amino acid residue
numbers are shown at the right of each line. Eleven
conserved subdomains of protein kinases are indicated by roman
numerals.
|
|
A computer search of the protein sequence data base
(GenBankTM) revealed that the kinase domain of AIK3 shares
71, 83, 69, 60, and 47% identity with those of human AIK (13, 14),
human AIK2 (15, 16), Xenopus pEg2 (21),
Drosophila Aurora (11), and budding yeast Ipl1 (10),
respectively. A multiple alignment of the kinase domains is shown in
Fig. 2. Amino acids that are the same as AIK3 are indicated by
asterisks. However, the N-terminal domain of AIK3 shares
little homology with other Aurora/Ipl1-related kinases. These results
indicate that AIK3 is a novel member of the Aurora/Ipl1-related protein
kinase family.
Chromosomal Localization of AIK3--
The chromosomal assignment
of human AIK3 was made by direct R-banding fluorescence
in situ hybridization (FISH) using a 1.0-kb AIK3
cDNA fragment as a probe. The positive signals of AIK3
gene were observed at chromosome 19q13.43 (Fig.
3). We examined 150 typical R-banded
(pro)metaphase spreads. 6% of them exhibited complete twin spots on
both homologues and 32% had incomplete signals and/or twin spots on
either or both homologues. No consistent fluorescent signals were
observed on other chromosomes.

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 3.
Chromosome assignment of AIK3
gene to 19q13.43. Chromosomal localization of
AIK3 gene on R-banded chromosomes using a 1.0-kb cDNA
fragment as a biotinylated probe. The hybridization signals are
indicated by arrows; they are localized to chromosome
19q13.43. The metaphase spreads were photographed with Nikon B-2A
(a and c) and UV-2A (b) filters.
R-band and G-band patterns are demonstrated in (a and
c) and (b), respectively.
|
|
To confirm the chromosomal localization of AIK3 gene, we
used the somatic cell hybrid panel (Coriell Cell Repositories). PCR amplification was performed as described under "Experimental
Procedures" using oligonucleotides specific for AIK3
cDNA. A band of 1.2 kb was amplified from DNAs containing human
chromosome 19 and in human genomic DNA (H), but no product
was seen in recipient Chinese hamster (CH) or mouse
(M) DNAs (Fig. 4).

View larger version (105K):
[in this window]
[in a new window]
|
Fig. 4.
PCR amplification of AIK3
genomic DNA from somatic cell hybrid panel. Oligonucleotides
specific for AIK3 nucleotide sequence and DNAs of somatic
cell hybrid mapping panel (Coriell Cell Repositories, mapping panel II)
were used for PCR reaction, and the products were analyzed on 2%
agarose gel stained with ethidium bromide. H, CH,
and M show the human, Chinese hamster, and mouse DNA,
respectively.
|
|
To refine the chromosomal localization of AIK3, we used the
Stanford G3 radiation hybrid mapping panel (Research Genetics). PCR
amplification was performed under the same conditions as in the somatic
cell hybrid panel. Bands (1.2 kb) of PCR product were detected in
lanes 6, 20, 31, 39, 45, 54, 65, 77, and 85 and
in human genomic DNA, but no product was seen in recipient Chinese hamster DNA (data not shown). Two-point maximum likelihood analysis, calculated by the Stanford Human Genome Center radiation hybrid web
server, indicated linkage to a genetic marker D19S828 with a
lod score of 8.645295. There was no evidence of linkage of
AIK3 to other genomic regions. The PCR product was subcloned
into pCR2.1 (Invitrogen) and sequenced both strands, and the product
has the same nucleotide sequence as AIK3 over 100 bases and
contains an intron(s) (data not shown). The results obtained by
in situ hybridization and radiation hybrid panel were in
accord, indicating that AIK3 is localized to human
chromosome 19q13.43.
AIK3 Expresses in Testis--
Expression of AIK is high
in testis, and AIK2 expression is observed in several
proliferating tissues, suggesting that the two proteins have a function
in cell proliferation. The tissue distribution of AIK3 was
also examined by Northern hybridization. 32P-Labeled
random-primed full-length AIK3 cDNA hybridized with a
single transcript of 1.3 kb. AIK3 expression was limited to testis (Fig. 5). The expression of
-actin was examined using the same blot, and almost identical
intensities of the bands were observed (38). These results suggest that
AIK3 may have a role(s) in cell proliferation.

View larger version (70K):
[in this window]
[in a new window]
|
Fig. 5.
AIK3 mRNA levels in human
tissues. Northern hybridization was performed with
poly(A)+ RNAs from human tissues. Blotted filters with 2 µg of poly(A)+ RNA from various human tissues were
hybridized with 32P-labeled full-length AIK3
cDNA probe. Size standards are indicated in kb at left.
|
|
Western Blotting Analyses of AIK3 in Cancer Cell Lines--
AIK is
reported to be amplified and overexpressed in several cancer cell lines
and tumor tissues (8, 14). To learn whether AIK3 is expressed in cancer
cells, its protein level was examined in some cancer cell lines by
Western blotting analyses. Elevated expression levels of AIK3 were
observed in several of these cell lines such as HepG2, HuH7,
MDA-MB-453, and HeLa cells, but in the other cancer cells examined the
protein was not detected (Fig. 6). AIK
was overexpressed in most of the examined cancer cell lines compared
with normal fibroblast (Fig. 6). The amounts of ERK2 and cyclin B were
almost identical in most of the cells, indicating that the protein
amount used was almost identical, and the cells used were at log phase.
A subset of cancer cells expressed AIK3 highly, but other cancer cells
expressed an undetectable level of the protein, suggesting the
different properties of these cell lines.

View larger version (55K):
[in this window]
[in a new window]
|
Fig. 6.
AIK3 protein levels in various cell
lines. Fifty µg of lysed protein from various cell lines was
loaded on each lane and subjected to Western blotting using anti-AIK3,
anti-AIK, anti-cyclin B, or anti-ERK2 antibodies.
|
|
Cell Cycle-dependent Expression of AIK3--
AIK and
AIK2 protein contents increased at G2/M phase compared with
G1/S phase (13, 15). Western blotting was performed to
learn cell cycle dependence of AIK3 expression. Anti-AIK3 antibody recognized a single band of 36 kDa, but an antibody preincubated with
glutathione S-transferase-AIK3 did not recognize the protein (Fig. 7A). To learn whether
AIK3 expression is also dependent on cell cycle progression, Western
blotting was performed using the lysates of HeLa cells arrested at S or
M phase (Fig. 7B). AIK3 protein level of the cells arrested
at M phase was higher than that of S phase arrested cells (Fig.
7B). This M phase arrest was induced by nocodazole,
indicating that AIK3 was induced by metaphase. Expression of cyclin B
was also higher at M phase than at S phase. However, the ERK2 protein
level did not change significantly during the cell cycle progression.
We also performed Western blotting using HeLa cell lysates of S phase
released cells (Fig. 7C). AIK3 protein level peaked at
12-20 h after S phase release and decreased to the basal level at
24 h (Fig. 7C). Expression of cyclin B was studied to
monitor the cell cycle progression, and the level changed in a similar
manner to AIK3, suggesting the predominant expression of AIK3 at M
phase. However, the ERK2 protein level did not change significantly
during the cell cycle progression.

View larger version (57K):
[in this window]
[in a new window]
|
Fig. 7.
Cell cycle-dependent expression
of AIK3 protein. A, lysates from HeLa cells (50 µg of
total protein) were loaded on each lane and subjected to Western
blotting using anti-AIK3 antibody (AIK3+) or that
preadsorbed with glutathione S-transferase-AIK3 protein
(AIK3 ). Size standards are indicated in kDa at
left. B, lysates from HeLa cells arrested at S or
M phases were subjected to Western blotting using anti-AIK3,
anti-cyclin B, or anti-ERK2 antibody. C, the lysates of the
cells released from S phase arrest were loaded on each lane and
subjected to Western blotting.
|
|
Subcellular Localization of AIK3 at Centrosome during M
Phase--
AIK is localized to the spindle pole region from prophase
to anaphase, and AIM-1 is localized to midbody at cytokinesis. The functions of AIK3 were also sought by examining subcellular
localization in HeLa cells using indirect immunofluorescence microscopy
(Fig. 8). AIK3 protein localized at
centrosome from anaphase to cytokinesis in dividing HeLa cells.
However, AIK3 was not detected at centrosome in interphase or pro- to
metaphase of HeLa cells, even though we looked at well over several
hundred dividing and interphase cells. The cell cycle stages of HeLa
cells were monitored by staining with 4,6-diamidino-2-phenylindole.
These results suggest that AIK3 plays a role(s) in centrosome function
at later stages of mitosis.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 8.
Localization of AIK3 to centrosome.
Subcellular localization of AIK3 in HeLa cells was examined by indirect
immunofluorescence microscopy with affinity purified polyclonal
anti-AIK3 antibody. The cell cycle stages of HeLa cells monitored by
staining with 4,6-diamidino-2-phenylindole are shown at
left.
|
|
 |
DISCUSSION |
We have identified a third human gene closely related to members
of the Aurora/Ipl1 family protein kinases, which are known to regulate
chromosome segregation in Drosophila (11) and yeast (10).
Temperature-sensitive mutants of IPL1 cause chromosome number alteration (12). Temperature-sensitive mutants of
aurora form a monopolar spindle and cannot segregate the
chromosomes (11). A single Aurora/Ipl1-related kinase is identified in
yeast and fly, but at least three kinases are present in mammalian
cells. It is intriguing to clarify the functional difference of these three human Aurora/Ipl1-related kinases. The three kinases have distinct N-terminal domains, which may contribute to their functional difference in human cells. AIK and AIK2 have Aurora boxes 1 and 2 that
share limited amino acid sequence identities (8), but AIK3 does not
have a related amino acid sequence (Fig. 1). The roles of Aurora boxes
must be further studied to elucidate the functions of the proteins.
The tissue distribution of AIK3 examined by Northern
blotting showed that expression was exclusively high only in testis
(Fig. 5). The expression of AIK/AYK1 is also high in testis
(13, 18). However, the expression of AIK2/STK-1/AIM-1 is
high in the proliferating tissues of thymus, testis, spleen, small
intestine, and colon (15, 17, 20), suggesting that AIK2 may have some
specialized function in these cells. All of the mammalian
Aurora/Ipl1-related kinases are rich in several cancer cells and
tissues with proliferating cells, suggesting that these have functions
in cell proliferation.
Expression levels of AIK3 in cancer cells were examined by Western
blotting to study whether AIK3 expression level was altered in tumor
cells like AIK. AIK3 protein level was high only in a subset of cancer
cells such as HepG2, HuH7, and HeLa cells and was hardly detected in
others, suggesting the different properties of these cell lines (Fig.
6). A computer search of the data base (GenBankTM) also
revealed the existence of AIK3 transcripts in proliferating cells such as testis (GenBankTM accession numbers AA421312
and AA421265) and cancer cells (GenBankTM accession number
AA484664). AIK expression was high in most of the cancer cells
examined. Considering the altered expression of AIK3 in several cancer
cell lines, it is tempting to speculate that AIK3 may function in tumorigenesis.
AIK3 gene was mapped to human chromosome 19q13.43 by
fluorescence in situ hybridization and by using somatic cell
hybrid and radiation hybrid cell panel (Figs. 3 and 4). The human
chromosomal region 19q13.43 was known to be deleted or translocated in
some cancer tissues (39-42), suggesting that disorganization of
AIK3 or another gene located in this chromosomal region is
involved in tumorigenesis. AIK gene (STK6) was
assigned to human chromosome 20q13.2-13.3 (13, 14). This chromosomal
region is amplified in some cancer tissues including breast and
colorectal cancers (24-28), and AIK overexpression was observed in
several cancer cell lines and tumor specimens (8, 14). In a recent
study, overexpression of AIK was shown capable of transforming rodent fibroblasts, indicating that AIK is oncogenic (8, 9). The AIK2 gene (STK12) was recently assigned to human
chromosome 17p13.1 (15). This chromosomal region contains p53 tumor
suppressor gene and is frequently deleted in some tumor tissues
(29-31). Overexpression of kinase-inactive rat AIM-1 disrupts cleavage
furrow formation without affecting nuclear division, resulting in
multinucleation. Thus, rat AIM-1 was shown to be required for proper
progression of cytokinesis in mammalian cells (20). Although point
mutations or enhanced expressions of AIK2 have not yet been identified, it is conceivable that AIK2 may have a role(s) in tumorigenesis. Considering the chromosome localization of AIK3 gene and the
altered expression of AIK3 in several cancer cell lines, it is tempting to speculate that AIK3 may function in tumorigenesis. We are now searching for an altered expression or a point mutation of AIK3 in
tumor tissues, and we are examining whether AIK3 can transform fibroblasts or not.
Since all of the previously known Aurora/Ipl1 family protein kinases
play roles in mitosis, it is conceivable that AIK3 may also function at
M phase. The present investigation provided evidence supporting this
notion. AIK3 is predominantly expressed in a subset of proliferating
tissues or cells. Cell cycle-dependent expression of AIK3
was observed in HeLa cells by Western blotting. The AIK3 protein level
is low in G1/S but high in G2/M (Fig. 7).
Timing of the appearance and disappearance of AIK3 and cyclin B was
almost identical, suggesting that they function in M phase. AIK3 is
localized at centrosome from anaphase to cytokinesis (Fig. 8). This
subcellular localization as well as the expression profile during cell
cycle progression suggests that AIK3 has a role(s) in centrosome or spindle function at M phase. To our knowledge, no protein other than
AIK3 has been reported to be localized to centrosome from anaphase to
cytokinesis. Western blotting with nocodazole-treated cells revealed
that AIK3 was induced by metaphase (Fig. 7B), but it was not
localized to centrosome at metaphase by fluorescence microscopy,
suggesting that some regulation such as phosphorylation may exist to
determine the localization of AIK3 at centrosome. AIK localized to
spindle pole from prophase to anaphase and AIK2 localized to midbody in
cytokinesis. Both AIK and AIK3 localized to centrosome at mitosis,
whereas the localization timings between the two proteins are
different, suggesting that they function at different steps in mitosis.
Although the subcellular localization of Aurora and Ipl1 has not been
studied, the phenotypes of these mutants suggest that their
localization may also be at centrosome or spindle pole body. Thus, the
members of the Aurora/Ipl1-family may play parts in organizing
microtubules during mitosis. We are now examining the effect of
overexpression of a dominant negative AIK3 on cell division.
 |
ACKNOWLEDGEMENTS |
We are grateful to Dr. H. Moriwaki (1st
Department of Internal Medicine, Gifu University) for HepG2 and HuH7
cells. We thank Dr. Y. Nozawa (Department of Biochemistry, Gifu
University) for allowing us to use a fluorescent microscope and for
helpful discussion. HeLa, HBL100, WI38, NB69, SK-N-SH, NB1RGB, and
MDA-MB-453 cells were obtained from RIKEN cell bank.
 |
FOOTNOTES |
*
This work was supported in part by a Grant-in-aid from the
Ministry of Education, Science, Sports, and Culture of Japan.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AB017332.
§
To whom correspondence should be addressed. Tel.: 81-58-267-2367;
Fax: 81-58-267-2950; E-mail: bunbyo{at}cc.gifu-u.ac.jp.
 |
ABBREVIATIONS |
The abbreviations used are:
PCR, polymerase
chain reaction;
kb, kilobase pair;
PBS, phosphate-buffered saline;
FISH, fluorescence in situ hybridization;
FCS, fetal calf
serum.
 |
REFERENCES |
-
Bunn, P. A.,
Krasnow, S.,
Makuch, R. W.,
Schlam, M. L.,
and Schechter, G. P.
(1982)
Blood
59,
528-535[Abstract]
-
Bringuier, P. P.,
Bouvier, R.,
Berger, N.,
Piaton, E.,
Revillard, J. P.,
Perrin, P.,
and Devonec, M.
(1993)
Cytometry
14,
559-564[Medline]
[Order article via Infotrieve]
-
Melchiorri, C.,
Chieco, P.,
Lisignoli, G.,
Marabini, A.,
and Orland, C.
(1993)
Cancer (Phila.)
72,
165-172[Medline]
[Order article via Infotrieve]
-
Shackney, S. E.,
Smith, C. A.,
Miller, B. W.,
Burholt, D. R.,
Murtha, K.,
Giles, H. R.,
Ketterer, D. M.,
and Pollice, A. A.
(1989)
Cancer Res.
49,
3344-3354[Abstract]
-
Wolf, G.,
Elez, R.,
Doermer, A.,
Holtrich, U.,
Ackermann, H.,
Stutte, H. J.,
Altmannsberger, H. M.,
Rubsamen-Waigmann, H.,
and Strebhardt, K.
(1997)
Oncogene
14,
543-549[CrossRef][Medline]
[Order article via Infotrieve]
-
Yuan, J.,
Horlin, A.,
Hock, B.,
Stutte, H. J.,
Rubsamen-Waigmann, H.,
and Strebhardt, K.
(1997)
Am. J. Pathol.
150,
1165-1172[Abstract]
-
Cahill, D. P.,
Lengauer, C., Yu, J.,
Riggins, G. J.,
Willson, J. K.,
Markowitz, S. D.,
Kinzler, K. W.,
and Vogelstein, B.
(1998)
Nature
392,
300-303[CrossRef][Medline]
[Order article via Infotrieve]
-
Bischoff, J. R.,
Anderson, L.,
Zhu, Y.,
Mossie, K.,
Ng, L.,
Souza, B.,
Schryver, B.,
Flanagan, P.,
Clairvoyant, F.,
Ginther, C.,
Chan, C. S. M.,
Novotny, M.,
Slamon, D. J.,
and Plowman, G. D.
(1998)
EMBO J.
17,
3052-3065[Abstract/Free Full Text]
-
Zhou, H.,
Kuang, J.,
Zhong, L.,
Kuo, W. L.,
Gray, J. W.,
Sahin, A.,
Brinkley, B. R.,
and Sen, S.
(1998)
Nat. Genet.
20,
189-193[CrossRef][Medline]
[Order article via Infotrieve]
-
Francisco, L.,
Wang, W.,
and Chan, C. S.
(1994)
Mol. Cell. Biol.
14,
4731-4740[Abstract]
-
Glover, D. M.,
Leibowitz, M. H.,
McLean, D. A.,
and Parry, H.
(1995)
Cell
81,
95-105[Medline]
[Order article via Infotrieve]
-
Chan, C. S.,
and Botstein, D.
(1993)
Genetics
135,
677-691[Abstract/Free Full Text]
-
Kimura, M.,
Kotani, S.,
Hattori, T.,
Sumi, N.,
Yoshioka, T.,
Todokoro, K.,
and Okano, Y.
(1997)
J. Biol. Chem.
272,
13766-13771[Abstract/Free Full Text]
-
Sen, S.,
Zhou, H.,
and White, R. A.
(1997)
Oncogene
14,
2195-2200[CrossRef][Medline]
[Order article via Infotrieve]
-
Kimura, M.,
Matsuda, Y.,
Yoshioka, T.,
Sumi, N.,
and Okano, Y.
(1999)
Cytogenet. Cell Genet.
82,
147-152
-
Shindo, M.,
Nakano, H.,
Kuroyanagi, H.,
Shirasawa, T.,
Mihara, M.,
Gilbert, D. J.,
Jenkins, N. A.,
Copeland, N. G.,
Yagita, H.,
and Okumura, K.
(1988)
Biochem. Biophys. Res. Commun.
244,
285-292[CrossRef]
-
Niwa, H.,
Abe, K.,
Kunisada, T.,
and Yamamura, K.
(1996)
Gene (Amst.)
169,
197-201[CrossRef][Medline]
[Order article via Infotrieve]
-
Yanai, A.,
Arama, E.,
Kilfin, G.,
and Motro, B.
(1997)
Oncogene
14,
2943-2950[CrossRef][Medline]
[Order article via Infotrieve]
-
Gopalan, G.,
Chan, C. S.,
and Donovan, P. J.
(1997)
J. Cell Biol.
138,
643-656[Free Full Text]
-
Terada, Y.,
Tatsuka, M.,
Suzuki, F.,
Yasuda, Y.,
Fujita, S.,
and Otsu, M.
(1998)
EMBO J.
17,
667-676[Abstract/Free Full Text]
-
Roghi, C.,
Giet, R.,
Uzbekov, R.,
Morin, N.,
Chartrain, I.,
Le Guellec, R.,
Couturier, A.,
Dor, M.,
Philippe, M.,
and Prigent, C.
(1998)
J. Cell Sci.
111,
557-572[Abstract/Free Full Text]
-
Kimura, M.,
Matsuda, Y.,
Eki, T.,
Yoshioka, T.,
Okumura, K.,
Hanaoka, F.,
and Okano, Y.
(1997)
Cytogenet. Cell Genet.
79,
201-207[Medline]
[Order article via Infotrieve]
-
Gopalan, G.,
Gilbert, D. J.,
Copeland, N. G.,
Jenkins, N. A.,
and Donovan, P. J.
(1998)
Mamm. Genome
9,
86-87[CrossRef][Medline]
[Order article via Infotrieve]
-
Kallioniemi, A.,
Kallioniemi, O. P.,
Piper, J.,
Tanner, M.,
Stokke, T.,
Chen, L.,
Smith, H. S.,
Pinkel, D.,
Gray, J. W.,
and Waldman, F. M.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
2156-2160[Abstract]
-
Isola, J. J.,
Kallioniemi, O. P.,
Chu, L. W.,
Fuqua, S. A.,
Hilsenbeck, S. G.,
Osborne, C. K.,
and Waldman, F. M.
(1995)
Am. J. Pathol.
147,
905-911[Abstract]
-
Iwabuchi, H.,
Sakamoto, M.,
Sakunaga, H.,
Ma, Y. Y.,
Carcangiu, M. L.,
Pinkel, D.,
Yang-Feng, T. L.,
and Gray, J. W.
(1995)
Cancer Res.
55,
6172-6180[Abstract]
-
Mertens, F.,
Kreicbergs, A.,
Rydholm, A.,
Willen, H.,
Carlen, B.,
Mitelman, F.,
and Mandahl, N.
(1994)
Cancer Genet. Cytogenet.
73,
147-151[Medline]
[Order article via Infotrieve]
-
Molenaar, W. M.,
van den Berg, E.,
Veth, R. P.,
Dijkhuizen, T.,
and de Vries, E. G.
(1994)
Genes Chromosomes Cancer
10,
66-70[Medline]
[Order article via Infotrieve]
-
McManus, D. T.,
Murphy, M.,
Arthur, K.,
Hamilton, P. W.,
Russell, S. E.,
and Toner, P. G.
(1996)
J. Pathol.
179,
177-182[CrossRef][Medline]
[Order article via Infotrieve]
-
Sakamoto, T.,
Nomura, N.,
Mori, H.,
and Wake, N.
(1996)
Gynecol. Oncol.
63,
173-179[CrossRef][Medline]
[Order article via Infotrieve]
-
Saxena, A.,
Clark, W. C.,
Robertson, J. T.,
Ikejiri, B.,
Oldfield, E. H.,
and Ali, I. U.
(1992)
Cancer Res.
52,
6716-6721[Abstract]
-
Stein, G. S.,
and Borun, T. W.
(1972)
J. Cell Biol.
52,
292-307[Abstract/Free Full Text]
-
Takahashi, E.,
Hori, T.,
Lawrence, J. B.,
McNeil, J.,
Singer, R. H.,
O'Connell, P.,
Leppert, M.,
and White, R.
(1989)
Jpn. J. Hum. Genet.
34,
307-311
-
Takahashi, E.,
Hori, T.,
O'Connell, P.,
Leppert, M.,
and White, R.
(1990)
Hum. Genet.
86,
14-16[Medline]
[Order article via Infotrieve]
-
Matsuda, Y.,
and Chapman, V. M.
(1995)
Electrophoresis
16,
261-272[Medline]
[Order article via Infotrieve]
-
Kimura, M.,
Hirono, M.,
Takemasa, T.,
and Watanabe, Y.
(1991)
J. Biochem. (Tokyo)
109,
399-403[Abstract]
-
Laemmli, L. K.
(1970)
Nature
227,
680-685[Medline]
[Order article via Infotrieve]
-
Kimura, M.,
Hattori, T.,
Matsuda, Y.,
Yoshioka, T.,
Sumi, N.,
Umeda, Y.,
Nakashima, S.,
and Okano, Y.
(1997)
Cytogenet. Cell Genet.
78,
107-111[Medline]
[Order article via Infotrieve]
-
Höglund, M.,
Gorunova, L.,
Andrën-Sandberg, A.,
Dawiskiba, S.,
Mitelman, F.,
and Johansson, B.
(1998)
Genes Chromosomes Cancer
21,
8-16[CrossRef][Medline]
[Order article via Infotrieve]
-
McDonald, J. M.,
Douglass, E. C.,
Fisher, R.,
Geiser, C. F.,
Krill, C. E.,
Strong, L. C.,
Virshup, D.,
and Huff, V.
(1998)
Cancer Res.
58,
1387-1390[Abstract]
-
Sreekantaiah, C.,
Davis, J. R.,
and Sandberg, A. A.
(1993)
Am. J. Pathol.
142,
293-305[Abstract]
-
Bicher, A.,
Ault, K.,
Kimmelman, A.,
Gershenson, D.,
Reed, E.,
and Liang, B.
(1997)
Gynecol. Oncol.
66,
36-40[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.